Themis Medicare Limited revenue from operations stood at Rs. 91 crore in Q2 FY23, as against Rs. 107.39 crore in Q2 FY22, a decrease of 15.26%.

EBITDA for the quarter was Rs. 21.34 crore as against Rs. 23.46 crore in Q2 FY22, decrease of 9.02%. EBITDA Margin stood at 23.45% whereas Q2 FY23 profit stood at Rs. 17.78 crore as against profit of Rs. 19.28 crore in Q2 FY22, a decrease of 7.76%. PAT Margin stood at 19.54% and EPS for the quarter stood at Rs. 19.33 crore.

For the half year ended September 30th, 2022 revenue from operations stood at Rs. 185.44 crore in H1 FY23, as against Rs. 219.89 crore in H1 FY22, a decrease of 15.67%.

EBITDA for the six months was Rs. 41.70 crore as against Rs. 63.93 crore in H1 FY22, decrease of 34.77% whereas EBITDA Margin stood at 22.49%.

H1 FY23 Profit stood at Rs. 35.18 crore as against profit of Rs. 50.47 crore in H1 FY22, decrease of 30.29%. PAT Margin stood at 18.97% and EPS for the period stood at Rs. 38.24.